CME Group Inc. (NASDAQ: CME) is 6.22% higher on its value in year-to-date trading and has touched a low of $129.97 and a high of $222.24 in the current 52-week trading range. The CME stock was last observed hovering at around $179.12 in the last trading session, with the day’s gains setting it 14.26% off its average median price target of $180.00 for the next 12 months. It is also 5.67% off the consensus price target high of $205.00 offered by 22 analysts, but current levels are -45.4% lower than the price target low of $133.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $193.38, the stock is 7.80% and 14.24% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.37 million and changing 7.96% at the moment leaves the stock 13.77% off its SMA200. CME registered -4.34% loss for a year compared to 6-month gain of 16.67%. The firm has a 50-day simple moving average (SMA 50) of $178.22 and a 200-day simple moving average (SMA200) of $169.30.
The stock witnessed a 6.56% loss in the last 1 month and extending the period to 3 months gives it a 16.50%, and is 8.12% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.11% over the week and 2.16% over the month.
CME Group Inc. (CME) has around 4360 employees, a market worth around $67.88B and $4.92B in sales. Current P/E ratio is 32.23 and Fwd P/E is 28.70. Profit margin for the company is 43.70%. Distance from 52-week low is 48.78% and -12.98% from its 52-week high. The company has generated returns on investments over the last 12 months (6.70%).
CME Group Inc. (CME) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for CME Group Inc. (CME) is a “Hold”. 22 analysts offering their recommendations for the stock have an average rating of 2.50, where 6 rate it as a Hold and 2 think it is a “Overweight”. 9 of the analysts rate the stock as a “Buy”. 4 analysts have rated the stock as a Sell or Underperform.
CME Group Inc. is expected to release its quarterly report on 05/05/2021 and quarterly earnings per share for the current quarter are estimated at $1.39 with sales reaching $1.1B over the same period.The EPS is expected to grow by 3.50% this year, but quarterly earnings will post 0.90% year-over-year. Quarterly sales are estimated to shrink -3.20% in year-over-year returns.
CME Group Inc. (CME) Top Institutional Holders
1,420 institutions hold shares in CME Group Inc. (CME), with 4.98M shares held by insiders accounting for 1.39% while institutional investors hold 88.13% of the company’s shares. The shares outstanding are 357.79M, and float is at 354.00M with Short Float at 1.63%. Institutions hold 86.90% of the Float.
The top institutional shareholder in the company is Capital World Investors with over 34.73 million shares valued at $5.81 billion. The investor’s holdings represent 9.68% of the CME Shares outstanding. As of Sep 29, 2020, the second largest holder is Vanguard Group, Inc. (The) with 28.6 million shares valued at $4.79 billion to account for 7.97% of the shares outstanding. The other top investors are Blackrock Inc. which holds 25.77 million shares representing 7.18% and valued at over $4.31 billion, while State Street Corporation holds 4.45% of the shares totaling 15.96 million with a market value of $2.67 billion.
CME Group Inc. (CME) Insider Activity
A total of 80 insider transactions have happened at CME Group Inc. (CME) in the last six months, with sales accounting for 66 and purchases happening 14 times. The most recent transaction is an insider sale by Piell Hilda Harris, the company’s Sr MD & Chief HR Officer. SEC filings show that Piell Hilda Harris sold 2,300 shares of the company’s common stock on Dec 21 at a price of $182.00 per share for a total of $0.42 million. Following the sale, the insider now owns 39704.0 shares.
CME Group Inc. disclosed in a document filed with the SEC on Dec 14 that GEPSMAN MARTIN J (Director) sold a total of 400 shares of the company’s common stock. The trade occurred on Dec 14 and was made at $178.44 per share for $71376.0. Following the transaction, the insider now directly holds 29417.0 shares of the CME stock.
Still, SEC filings show that on Dec 14, CRONIN KATHLEEN M (Sr MD Gen Counsel & Corp Secr) disposed off 6,208 shares at an average price of $178.41 for $1.11 million. The insider now directly holds 42,885 shares of CME Group Inc. (CME).
CME Group Inc. (CME): Who are the competitors?
The company’s main competitors (and peers) include MarketAxess Holdings Inc. (MKTX) that is trading 45.26% up over the past 12 months. Nasdaq Inc. (NDAQ) is 27.23% up on the 1-year trading charts. Short interest in the company’s stock has risen 2.08% from the last report on Nov 12, 2020 to stand at a total of 5.66 million short shares sold with a short interest ratio of 3.69.